(Q48466917)

11 February 2018

title

Laminin inhibits Abeta42 fibril formation in vitro (English)

1 reference

11 February 2018

author name string

A Monji

1 reference

11 February 2018

K Tashiro

1 reference

11 February 2018

I Yoshida

1 reference

11 February 2018

N Tashiro

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 March 1998

1 reference

11 February 2018

published in

Brain Research

1 reference

11 February 2018

volume

788

1 reference

11 February 2018

issue

1-2

1 reference

11 February 2018

page(s)

187-190

1 reference

11 February 2018

alpha-1-antichymotrypsin interaction with A beta (1-40) inhibits fibril formation but does not affect the peptide toxicity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Glutamine synthetase-induced enhancement of beta-amyloid peptide A beta (1-40) neurotoxicity accompanied by abrogation of fibril formation and A beta fragmentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Laminin inhibits amyloid-beta-peptide fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Extracellular matrix regulates the amount of the beta-amyloid precursor protein and its amyloidogenic fragments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Inhibition of Alzheimer β-Peptide Fibril Formation by Serum Amyloid P Component

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Laminin and its neurite outgrowth-promoting domain in the brain in Alzheimer's disease and Down's syndrome patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Nicotine inhibits amyloid formation by the beta-peptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Amyloid beta-protein and the genetics of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Amyloid β-Protein (Aβ) 1–40 But Not Aβ1–42 Contributes to the Experimental Formation of Alzheimer Disease Amyloid Fibrils in Rat Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

Mechanisms of neuronal degeneration in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901542-4

10.1016/S0006-8993(97)01542-4

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018